TO THE QUESTION ABOUT IMMUNOLOGIES CRITERIAS OF EFFICIENCY OF ANTIVIRUS THERAPY OF A CHRONIC VIRUS HEPATITES C
https://doi.org/10.15789/1563-0625-2006-5-6-673-678
Abstract
Abstract. The group of patients in amount 45 person received the standard combined therapy by preparations of recombinant IFN-α in combination with ribavirin. The positive effect of standard antivirus treatment at patients with chronic HCV-infection associated with increase of level of IL-2, decrease of levels of TNF-α, IL-1α, IL-12р40, IL-12р70 and IL-10 in peripheral serum. It has allowed to use them as noninvasive markers of the steady virologic answer during treatment of a chronic HCV-infection.
About the Authors
L. Ph. Sklyar
ГОУ ВПО «Владивостокский государственный медицинский университет», Владивосток
Russian Federation
Russian Federation
E. V. Markelova
ГОУ ВПО «Владивостокский государственный медицинский университет», Владивосток
Russian Federation
Russian Federation
References
1. Никулкина Е.Н., Крель П.Е., Лопаткина Т.Н., Игнатова Т.М. Эффективность комбинированной терапии пегинтерфероном альфа-2b (ПегИнтроном) и рибавирином (Ребетолом) первичных больных хроническим гепатитом С // Клинич. фармакология и терапия. – 2004. – Т. 13. - № 2. – С. 48-52.
2. Amaraa R., Mareckova H., Urbanek P. Immunological predictors of different responses to combination therapy with interferon alpha and ribavirin in patients with chronic hepatitis // J. Gastroenterology. 2003. – Vol. 38. - N 3. – P. 254.
3. Berg T., Sarrazin C., Herrmann E. Prediction of treatment outcome in patients with chronic hepatitis C: significance of baseline parameters and viral dynamics during therapy // Hepatology. – 2003. – Vol. 37. – P. 600-609.
4. Burroughs A.K. Posttransplantation prevention and treatment of recurrent hepatitis C // Liver transpl. – 2000. – Vol. 6 - N 2. – P. 35-40.
5. Craxi A., Licata A. Clinical trial results of peginterferons in combination with ribavirin // Semin. Liver Dis. – 2003. – Vol. 23. - N 1. – P. 35-46.
6. Hadziyannis S.J., Sette ir H., Morgan T.R. Peginterferon alfa-2a and ribavirine combination therapy in chronic hepatitis C. A randomized study of treatment duration and ribavirine dose // Ann. Intern. Med. – 2004. – Vol. 140. – P. 346-355.
7. Gopal D.V., Rabcin J.M., Berk B.S. Treatment of progressive hepatitis C recurrence after liver transplantation with combination interferon plus ribavirin // Liver transpl. – 2001. – N 7. – P. 181-190.
8. McHutchison J., Gordon S.C., Schiff E.R. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C // N. Engl. J. Med. – 1998. – Vol. 339. – P. 1485-1492.
9. Meurs E. Mechanisms of antiviral action of interferon // Virologie. – 1997. – Vol. 1. – P. 481-498.
10. National Institutes of Health Consensus Development Conference Statement: Management of Hepatitis C: 2002 // Hepatology. – 2002. – Vol. 36. – P. 2-20.
11. Peters M. Action of cytokines on the immune response and viral interactions: an overview // Hepatology. – 1996. – Vol. 23. – P. 909-916.
12. Pestka S., Krause C.D., Walter M.R. Interferons, interferon-like cytokines, and their receptors // Immunological reviews. – 2004. – Vol. 202. – P. 28-32.
13. Poynard T., McHutchison J., Manns M. Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C // Gastroenterology. – 2002. – Vol. 122. – P. 1303-1313.
14. Randall G., Rice C.M. Hepatitis C virus cell culture replication systems: their potential use for the development of antiviral therapies // Curr. Opin. Infect. Dis. – 2001. - Vol. 14. – P.743-747.
15. Wedemeyer H., Cornberg B., Manns M.P. Immunopathogenesis and therapy of hepatitis C // Liver Immunology / M. ed Gershwin, London: Academic Press. - 2003. – Ch. 16. – P. 223-248.
Review
For citations:
Sklyar L.P., Markelova E.V. TO THE QUESTION ABOUT IMMUNOLOGIES CRITERIAS OF EFFICIENCY OF ANTIVIRUS THERAPY OF A CHRONIC VIRUS HEPATITES C. Medical Immunology (Russia). 2006;8(5-6):673-678. (In Russ.) https://doi.org/10.15789/1563-0625-2006-5-6-673-678
Views:
749
Email this article 